Related Experiment Video
Updated: Aug 15, 2026
09:37
Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine
Published on: August 24, 2018
Anisodamine restores bowel circulation in burn shock
Summary
Anisodamine improved gastric mucosal perfusion and reduced endotoxemia in burn patients. This anticholinergic drug shows promise in treating burn shock by addressing splanchnic vasoconstriction.
Area of Science:
- Burn resuscitation
- Gastrointestinal physiology
- Pharmacology
Background:
- Severe burn injuries cause hypovolemia and impaired intestinal oxygen delivery.
- Prolonged gut hypoxia can lead to mucosal barrier dysfunction and endotoxemia.
- Splanchnic vasoconstriction contributes to inadequate gut perfusion during burn shock.
Purpose of the Study:
- To evaluate the efficacy of anisodamine in improving gastric mucosal perfusion in burn patients.
- To assess the impact of anisodamine on reducing endotoxemia and TNF levels post-burn injury.
- To determine if anisodamine can be a valuable adjunct to standard burn resuscitation.
Main Methods:
- A study involving burn patients with extensive TBSA (total body surface area) burn injuries.
- Comparison of a control group receiving aggressive fluid resuscitation with a group receiving anisodamine.
- Measurement of gastric intramucosal pH (pHi), plasma endotoxin, and tumor necrosis factor (TNF) levels.
Main Results:
- Aggressive fluid resuscitation normalized global hypovolemia within 12 hours, but gastric pHi remained low at 48 hours.
- Anisodamine administration led to a return of gastric pHi to normal levels before 48 hours post-injury.
- Plasma endotoxin and TNF levels were significantly lower in the anisodamine group compared to controls at 72 hours.
Conclusions:
- Anisodamine may be a valuable adjunct to burn shock resuscitation.
- The drug shows potential in mitigating endogenous endotoxemia resulting from splanchnic vasoconstriction.
- Mild side effects like abdominal distention and tachycardia were observed.
Related Concept Videos
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:24Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...